Endobronchial Ultrasound Biopsy Market is Estimated to Witness High...

Endobronchial Ultrasound Biopsy Market is Estimated to Witness High Growth Owing to Increasing Incidence of Lung Cancer

Posté 2024-01-08 08:34:50

2KB

Endobronchial ultrasound biopsy (EBUS-TBNA) is a minimally invasive medical procedure used to examine mediastinal and hilar lymph nodes in pulmonary malignancies. It helps in the diagnosis and staging of lung cancer and sarcoidosis. EBUS-TBNA uses an ultrasound bronchoscope, which incorporates an ultrasound probe at its tip. With real-time ultrasound imaging, suspicious lymph nodes can be visualized and biopsied under direct vision. This procedure provides both diagnostic tissue samples and staging information without major surgery.

The global Endobronchial Ultrasound Biopsy Market is estimated to be valued at US$ 722.67 Bn in 2023 and is expected to exhibit a CAGR of 7.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:

The growing incidence of lung cancer is expected to drive the endobronchial ultrasound biopsy market growth over the forecast period. Lung cancer is one of the leading cause of cancer-related deaths worldwide. According to WHO, lung cancer accounted for nearly 2.2 million new cases and 1.8 million deaths globally in 2020. Early detection of lung cancer improves the chances of cure. Endobronchial ultrasound biopsy helps in precise localization and biopsy of lymph nodes, thus enabling early diagnosis and staging of lung cancer. The increasing adoption of minimally invasive procedures is also propelling the market growth. EBUS-TBNA is associated with fewer complications and shorter recovery time compared to mediastinoscopy. The real-time ultrasound guidance and ability to safely obtain samples from deep lymph nodes majorly contribute to its rising preference over traditional invasive methods.

SWOT Analysis
Strength: The endobronchial ultrasound biopsy market has witnessed significant technological advances in recent years. New devices offer improved imaging capabilities and ability to obtain tissue samples. This has enabled more accurate diagnosis of lung cancers and other diseases. Advanced visualization features allow clinicians to better target areas for biopsy. The procedure is also less invasive compared to conventional techniques.

Weakness: Endobronchial ultrasound biopsy is an expensive procedure and the devices have high upfront costs. This poses affordability challenges in price-sensitive developing markets. The learning curve for physicians is also steep, requiring extensive training to perform the technique properly. procedure time can be lengthy, putting strain on clinic/hospital resources.

Opportunity: Rising incidence of lung cancer worldwide presents sizable opportunities for market growth. Early detection is crucial but remains a challenge. EBUS biopsy helps address this clinical need by providing minimally-invasive sampling of suspicious lung lesions. Applications are expanding beyond cancer to include diagnosis of sarcoidosis and interstitial lung disease. Adoption in veterinary medicine could be another potential growth area.

Threats: Competition from alternative diagnostic modalities poses threats. Advanced thoracoscopic procedures and low-dose computed tomography threaten take rate for EBUS biopsy. Reimbursement uncertainty particularly in the US represents a challenge. Physicians may prefer other newer technologies offering additional advantages. Overall market saturation in developed countries limits room for sales expansion.

Key Takeaways
Global Endobronchial Ultrasound Biopsy Market Size is expected to witness high growth over the forecast period Supported by various technological advancements and growing prevalence of lung diseases.

Regional analysis: North America currently dominates the endobronchial ultrasound biopsy market owing to presence of major players and advanced healthcare infrastructure. However Asia Pacific is expected to grow at fastest pace due to rising healthcare expenditures, increasing awareness about lung diseases and growing geriatric population. Countries like China and Indiaare expected to offer lucrative opportunities.

Key players: Key players operating in the endobronchial ultrasound biopsy market are Olympus, Medtronic, Cook Medical LLC, PENTAX Medical, FUJIFILM Corporation, Veran Medical Technologies and Clarus Medical LLC. They are focusing on new product launches and geographic expansions to strengthen their market position.